HSD17B2 and colorectal carcinoma: The expression of HSD17B2, which catalyzes estradiol (E2) to E1 in human CRC tissue, was also proven to be downregulated in colon cancers and predicts poor prognosis, suggesting an important role of estrogen metabolism in CRC progression (58).